INDIANAPOLIS, May 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Humalog ® 200 units/mL KwikPen ® (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to insulin lispro ...

Doctors prescribe Humalog (insulin lispro) to help improve blood sugar levels in people with diabetes. This drug can interact with alcohol and other medications. For example, Humalog can interact with ...

Insulin remains one of the most important treatments for people living with diabetes. Whether someone has Type 1 diabetes or advanced Type 2 diabetes, insulin therapy helps control blood sugar levels, ...

The drugmaker Eli Lilly will begin selling a cheaper version of its most popular insulin, Humalog, in an effort to head off criticism about the rising costs of prescription drugs, the company said ...

A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. The company announced its plans in March amid growing ...

Eli Lilly said it plans to roll out a half-price version of its Humalog insulin, an effort that comes amid rising scrutiny and criticism over the surging cost of the life-saving medication. The price ...

Drugmaker Eli Lilly patted itself on the back this week for offering an “authorized generic” version of its Humalog insulin for about half the current list price. “Solutions that lower the cost of ...

A half-price version of Eli Lilly's popular Humalog insulin is now on sale, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring prices ...

Eli Lilly says the "net price" for insulin fell to $135 a patient a month in 2018 from $147 in 2014. The insulin's average list price rose 51.9 percent to $594 per patient each month. Pharmaceutical ...

Marks approval of first concentrated mealtime insulin analog in the U.S. and expands Lilly's portfolio of medicines for people with type 1 and type 2 diabetes INDIANAPOLIS, May 27, 2015 /PRNewswire/ - ...